Source: Eur Respir J 2001; 18: 507-514
Disease area: Airway diseases, Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Hermans C., Petrek M., Kolek V., Weynand B., Pieters T., Lambert M., Bernard A.. Serum Clara cell protein (CC16), a marker of the integrity of the air-blood barrier in sarcoidosis. Eur Respir J 2001; 18: 507-514

Member's Comments

No comment yet.

Related content which might interest you: Serum levels of CC16, SP-A and SP-B reflect tobacco-smoke exposure in asymptomatic subjects Source: Eur Respir J 2002; 20: 1152-1161 Year: 2002 Clara cell secretory protein (CC16) and surfactant protein D (SPD) in sputum supernatant in severe refractory asthma (SRA) Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers Year: 2012 Clara cell protein as a biomarker for ozone-induced lung injury in humans Source: Eur Respir J 2003 Dec 01;22(6):883-888 Year: 2003 Clara cells drive eosinophil accumulation in allergic asthma Source: Eur Respir J 2012; 39: 429-438 Year: 2012 Clara cell specific protein (CC16) after LPS inhalation in healthy subjects Source: Annual Congress 2003 - Mechanisms of lung injury: from bench to bedside Year: 2003 Clara cell protein (CC16) in serum and urine after exercise challenge Source: Annual Congress 2012 - Bronchial challenge as a biomarker of respiratory disease Year: 2012 Clara cell protein (CC16) as a biomarker for ozone exposure in humans Source: Eur Respir J 2002; 20: Suppl. 38, 569s Year: 2002 Swimmers have evidence of epithelial dysfunction measured as increased urinary concentration of Clara cell protein (CC16) after swim exercise Source: Annual Congress 2009 - Novel insights in exercise physiology from cells to humans Year: 2009 Production of Clara cell protein by human bronchiolar epithelial cells is reduced by INF-gamma Source: Eur Respir J 2004; 24: Suppl. 48, 99s Year: 2004 Diurnal variation in the serum levels of Clara cell protein (CC16) in humans Source: Eur Respir J 2003; 22: Suppl. 45, 75s Year: 2003 Neutrophil predominance phenotype in bronchial asthma. Therapeutic implication and the role of Clara cell 16-kD protein Source: Annual Congress 2007 - Invasive and noninvasive methods to assess airway inflammation Year: 2007 LPS-induced lung inflammation is linked to increased epithelial permeability: role of MLCK Source: Eur Respir J 2005; 25: 789-796 Year: 2005 Increased expression of Lysosomal-associated membrane protein 1 (LAMP-1) found in small airway epithelium of COPD may have functional consequence and role in autophagy. Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes Year: 2017 Clara cell secretory protein (CC16): possibility of detection in exhaled breath condensate Source: Annual Congress 2007 - Noninvasive evaluation of airway diseases Year: 2007 Clara cell protein 16 (CC16) and markers of fibrosis in exogenous toxic (ETA) and exogenous allergic (EAA) alveolites Source: International Congress 2014 – Environment and mechanisms Year: 2014 Increased galectin-3 expression and intra-epithelial neutrophils in small airways in severe COPD Source: Eur Respir J 2007; 29: 914-922 Year: 2007 Clara cell secretory protein and its mRNA expression in induced sputum of acute bacterial exacerbations of COPD Source: Eur Respir J 2002; 20: Suppl. 38, 543s Year: 2002 Hyaluronic acid increases the airway epithelial integrity Source: Annual Congress 2005 - Airway epithelial cells in asthma and COPD Year: 2005 Epithelial fibroblast triggering and interactions in pulmonary fibrosis Source: Eur Respir Rev 2008; 17: 123-129 Year: 2008